Melqart Asset Management (UK) Ltd - TAKEDA PHARMACEUTICAL CO LTD ownership

TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 348 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q2 2019. The put-call ratio across all filers is 0.95 and the average weighting 0.3%.

Quarter-by-quarter ownership
Melqart Asset Management (UK) Ltd ownership history of TAKEDA PHARMACEUTICAL CO LTD
ValueSharesWeighting
Q4 2019$30,720,000
+6.8%
1,557,000
-6.9%
2.57%
-1.5%
Q3 2019$28,764,000
-0.9%
1,672,350
+2.0%
2.61%
+30.8%
Q2 2019$29,028,000
-3.8%
1,640,000
+10.7%
2.00%
-28.7%
Q1 2019$30,171,0001,481,1372.80%
Other shareholders
TAKEDA PHARMACEUTICAL CO LTD shareholders Q2 2019
NameSharesValueWeighting ↓
TFG Asset Management GP Ltd 1,903,662$29,449,6525.37%
MANAGED ASSET PORTFOLIOS, LLC 1,736,416$26,862,3564.12%
Y.D. More Investments Ltd 1,381,550$21,372,5794.11%
Clean Yield Group 533,157$8,167,9653.62%
XY Capital Ltd 143,697$2,222,9931.28%
Mondrian Investment Partners LTD 4,081,715$61,225,7251.26%
Capricorn Fund Managers Ltd 204,892$3,169,6791.10%
Legacy Wealth Asset Management, LLC 124,967$1,933,2390.71%
HAP Trading, LLC 263,679$4,079,1140.65%
BRANDES INVESTMENT PARTNERS, LP 1,802,036$27,877,4930.54%
View complete list of TAKEDA PHARMACEUTICAL CO LTD shareholders